Bioventus
BVS
148 hedge funds and large institutions have $373M invested in Bioventus in 2025 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 58 increasing their positions, 37 reducing their positions, and 13 closing their positions.
115% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 13
57% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 37
13% more capital invested
Capital invested by funds: $329M → $373M (+$44.4M)
10% more funds holding
Funds holding: 135 → 148 (+13)
1.42% more ownership
Funds ownership: 73.51% → 74.93% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$2.79M |
| 2 |
MIM
Meros Investment Management
Dallas,
Texas
|
+$2.27M |
| 3 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$1.94M |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.7M |
| 5 |
D.E. Shaw & Co
New York
|
+$1.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$3.68M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$1.75M |
| 3 |
Renaissance Technologies
New York
|
-$1.41M |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$1.06M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$547K |
BVS Hedge Fund Activity: Q4 2025 in Review
148 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in Bioventus (BVS) for Q4 2025, worth a combined $373M — up 13% from $329M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new BVS positions and 13 closed out — a net gain of 15 holders — while 58 added to existing stakes and 37 trimmed.
The largest buyer was Essex Investment Management, opening a new position worth an estimated $2.79M. The largest seller was Divisadero Street Capital Management, cutting an estimated $3.68M.
- 148 institutional investors held Bioventus (BVS) as of Q4 2025, up from 135 in Q3 2025.
- Funds reported $373M of Bioventus stock for Q4 2025, up 13% quarter-over-quarter.
- 28 funds opened new Bioventus positions in Q4 2025 and 13 closed out, a net change of +15 holders.
- The largest Bioventus buyer in Q4 2025 was Essex Investment Management, an estimated $2.79M added.
- The largest Bioventus seller in Q4 2025 was Divisadero Street Capital Management, an estimated $3.68M sold.
Based on aggregated 13F filings for Q4 2025.